Human and murine tuberculosis as models for immuno-endocrine interactions

  • G. A. W. Rook
  • R. Hernandez-Pando
  • R. Baker
  • H. Orozco
  • K. Arriaga
  • L. Pavon
  • M. Streber
Chapter

Abstract

Recent studies of human and murine tuberculosis have revealed striking changes in adrenal steroid output and metabolism. In this review we use tuberculosis as a model on which to base discussion of the ways in which these changes, even when not disease-specific, may impact upon the function of T lymphocytes during chronic inflammation. Other chapters in this volume amplify further several of the topics highlighted in this one.

Keywords

Human Immunodeficiency Virus Type Migration Inhibition Factor Mineralocorticoid Receptor During This Phase Delay Hyper Diurnal Rhythm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Scott GM, Murphy PG, Gemidjioglu ME (1990) Predicting deterioration of treated tuberculosis by corticosteroid reserve and C-reactive protein. J Infect 21:61–69PubMedGoogle Scholar
  2. 2.
    Post FA, Soule SG, Willcox PA, Levitt NS (1994) The spectrum of endocrine dysfunction in active pulmonary tuberculosis. Clin Endocrinol 40:367–371Google Scholar
  3. 3.
    Onwubalili JK, Scott GM, Smith H (1986) Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature. Q J Med 59:599–610PubMedGoogle Scholar
  4. 4.
    Blauer KL, Poth M, Rogers WM, Bernton EW (1991) Dehydroepiandrosterone antagonises the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129:3174–3179PubMedGoogle Scholar
  5. 5.
    Daynes RA, Araneo BA, Dowell TA, Huang K, Dudley D (1990) Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 171:979–996PubMedGoogle Scholar
  6. 6.
    Wright BE, Porter JR, Browne ES, Svec F (1992) Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats. Int J Obes 16:579–583Google Scholar
  7. 7.
    Rook GAW, Onyebujoh P, Stanford JL (1993) TH1->TH2 switch and loss of CD4 cells in chronic infections; an immuno-endocrinological hypothesis not exclusive to HIV. Immunol Today 14:568–569PubMedGoogle Scholar
  8. 8.
    Rook GAW, Hernandez-Pando R, Lightman S (1994) Hormones, peripherally activated prohormones, and regulation of the TH1/TH2 balance. Immunol Today 15:301–303PubMedGoogle Scholar
  9. 9.
    Hernandez-Pando R, Orozco H, Honour JP, Silva J, Leyva R, Rook GAW (1995) Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis? FEMS Immunol Med Microbiol 12:63–72PubMedGoogle Scholar
  10. 10.
    Crowley S, Holownia P, Hindmarsh P, Brook CGD, Honour JW (1991) The acute adrenal response to physiological ACTH. J Endocrinol 130:475–479PubMedGoogle Scholar
  11. 11.
    Roberts NA, Barton RN, Horan MA (1990) Ageing and sensitivity of the adrenal gland to physiological doses of ACTH in man. J Endocrinol 126:507–513PubMedGoogle Scholar
  12. 12.
    Reznek RH, Armstrong P (1994) The adrenal gland. Clin Endocrinol 40:561–576Google Scholar
  13. 13.
    Lurie MB (1964) Resistance to tuberculosis; experimental studies in native and acquired defensive mechanisms Harvard University Press, Cambridge, Mass.Google Scholar
  14. 14.
    Sarma GR, Chandra I, Ramachandran G, Krishnamurthy PV, Kumaraswami V, Prabhakar R (1990) Adrenocortical function in patients with pulmonary tuberculosis. Tubercle 71:277–282PubMedGoogle Scholar
  15. 15.
    Wilckens T (1995) Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction. Trends Pharmacol Sci 16:193–197PubMedGoogle Scholar
  16. 16.
    Stöcklin E, Vissler M, Gouilleux F, Groner B (1996) Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726–728PubMedGoogle Scholar
  17. 17.
    Wiegers GJ, Croiset G, Reul JM, Holsboer F, de Kloet ER (1993) Differential effects of corticosteroids on rat peripheral blood T-lymphocyte mitogenesis in vivo and in vitro. Am J Physiol 265:E825–E830PubMedGoogle Scholar
  18. 18.
    Wiegers GJ, Reul JM, Holsboer F, de Kloet ER (1994) Enhancement of rat splenic lymphocyte mitogenesis after short-term preexposure to corticosteroids in vitro. Endocrinology 135:2351–2357PubMedGoogle Scholar
  19. 19.
    Oakley RH, Sar M, Cidlowski JA (1996) The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem 271:9550–9559PubMedGoogle Scholar
  20. 20.
    Vacchio MS, Papdopoulos V, Ashwell JD (1994) Steroid production in the thymus: implications for thymocyte selection. J Exp Med 179:1835–1846PubMedGoogle Scholar
  21. 21.
    King LB, Vacchio MS, Dixon K, Hunziker R, Margulies DH, Ashwell JD (1995) A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 3:647–656PubMedGoogle Scholar
  22. 22.
    Migliorati G, Pagliacci C, Moraca R, Crocicchio F, Nicoletti I, Riccardi C (1992) Interleukins modulate glucocorticoid-induced thymocyte apoptosis. Int J Clin Lab Res 21:300–303PubMedGoogle Scholar
  23. 23.
    Dougherty TF, Berliner ML, Berliner DL (1960) 1lß-hydroxy dehydrogenase system activity in thymi of mice following prolonged cortisol treatment. Endocrinology 66:550–558PubMedGoogle Scholar
  24. 24.
    Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, Burke DS (1990) Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr 3:144–151PubMedGoogle Scholar
  25. 25.
    Brinkmann V, Kristofic C (1995) Regulation by corticosteroids of Thl and Th2 cytokine production in human CD4+ effector T cells generated from CD45R0- and CD45R0+ subsets. J Immunol 155:3322–3328PubMedGoogle Scholar
  26. 26.
    Krouwels FH, van der Heijden JF, Lutter R, van Neerwen RJJ, Jansen HM, Out TA (1996) Glucocorticoids affect functions of airway-and blood-derived human T cell clones, favoring the Thl profile through two mechanisms. Am J Respir Cell Mol Biol 14:388–397PubMedGoogle Scholar
  27. 27.
    Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D (1996) Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 156:2406–2412PubMedGoogle Scholar
  28. 28.
    Brown DH, Sheridan J, Pearl D, Zwilling BS (1993) Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: differential responses of Mycobacterium bovis BCG-resistant and -susceptible mice. Infect Immun 61:4793–4800PubMedGoogle Scholar
  29. 29.
    Batuman OA, Ferrero AP, Diaz A, Jimenez SA (1991) Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest 88:1574–1580Google Scholar
  30. 30.
    Corrigan CJ, Hamid Q, North J, Barkans J, Moqbel R, Durham S et al. (1995) Peripheral blood CD4 but not CD8 T-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 12:567–578PubMedGoogle Scholar
  31. 31.
    Zwilling BS (1992) Stress affects disease outcomes. ASM News 58:23–25Google Scholar
  32. 32.
    Bernton E, Hoover D, Galloway R, Popp K (1995) Adaptation to chronic stress in military trainees. Adrenal androgens, testosterone, glucocorticoids, IGF-1 and immune function. Ann NY Acad Sci 774:217–231PubMedGoogle Scholar
  33. 33.
    Fischer A, Konig W (1991) Influence of cytokines and cellular interactions on the glucocorticoid-induced Ig (E, G, A, M) synthesis of peripheral blood mononuclear cells. Immunology 74:228–233PubMedGoogle Scholar
  34. 34.
    Wu CY, Sarfati M, Heusser C, Fournier S, Rubio-Trujillo M, Peleman R et al. (1991) Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes. J Clin Invest 87:870–877Google Scholar
  35. 35.
    Guida L, O’Hehir RE, Hawrylowicz CM (1994) Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils. Blood 84:2733–2740PubMedGoogle Scholar
  36. 36.
    Padgett DA, Sheridan JF, Loria R (1995) Steroid hormone regulation of a polyclonal Th2 immune response. Ann NY Acad Sci 774:323–325PubMedGoogle Scholar
  37. 37.
    Opstad PK (1994) Circadian rhythm of hormones is extinguished during prolonged physical stress, sleep and energy deficiency in young men. Eur J Endocrinol 131:56–66PubMedGoogle Scholar
  38. 38.
    Lortholary O, Christeff N, Casassus P, Thobie N, Veyssier P, Trogoff B et al. (1996) Hypothalamo-pituitary-adrenal function in human immunodeficiency virus-infected men. J Clin Endocrinol Metab 81:791–796PubMedGoogle Scholar
  39. 39.
    Sauer J, Castren M, Hopfner U, Holsboer F, Stalla GK, Arzt E (1996) Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor. J Clin Endocrinol Metab 81:73–79Google Scholar
  40. 40.
    Petrovsky N, Harrison LC (1995) Th1 and Th2: swinging to a hormonal rhythm. Immunol Today 16:605PubMedGoogle Scholar
  41. 41.
    Petrovsky N, McNair P, Harrison LC (1994) Circadian rhythmicity of interferon-gamma production in antigen-stimulated whole blood. Chronobiologia 21:293–300PubMedGoogle Scholar
  42. 42.
    Hiemke C, Brunner R, Hammes E, Muller H, Meyer ZBK, Lohse AW (1995) Circadian variations in antigen-specific proliferation of human T lymphocytes and correlation to cortisol production. Psychoneuroendocrinology 20:335–342PubMedGoogle Scholar
  43. 43.
    Fukuda R, Ichikawa Y, Takaya M, Ogawa Y, Masumoto A (1994) Circadian variations and prednisolone-induced alterations of circulating lymphocyte subsets in man. Intern Med 33:733–738PubMedGoogle Scholar
  44. 44.
    Pownall R, Kabler PA, Knapp MS (1979) The time of day of antigen encounter influences the magnitude of the immune response. Clin Exp Immunol 36:347–354PubMedGoogle Scholar
  45. 45.
    Sothern RB, Roitman-Johnson B, Kanabrocki EL, Yager JG, Roodell MM, Weatherbee JA et al. (1995) Circadian characteristics of circulating interleukin-6 in men. J Allergy Clin Immunol 95:1029–1035PubMedGoogle Scholar
  46. 46.
    Young MR, Matthews JP, Kanabrocki EL, Sothern RB, Roitman JB, Scheving LE (1995) Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor in men. Chronobiol Int 12:19–27PubMedGoogle Scholar
  47. 47.
    Lemmer B, Schwulera U, Thrun A, Lissner R (1992) Circadian rhythm of soluble interleukin-2 receptor in healthy individuals. Eur Cytokine Netw 3:335–336PubMedGoogle Scholar
  48. 48.
    Martini E, Muller JY, Doinel C, Gastal C, Roquin H, Douay L et al. (1988) Disappearance of CD4-lymphocyte circadian cycles in HIV-infected patients: early event during asymptomatic infection. Aids 2:133–134PubMedGoogle Scholar
  49. 49.
    Andrieu JM, Lu W, Levy R (1995) Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. J Infect Dis 171:523–530PubMedGoogle Scholar
  50. 50.
    Clerici M, Bevilacqua M, Vago T, Shearer GM, Norbiato G (1994) An immunoendocrinological hypothesis of HIV infection. Lancet 343:1552–1553PubMedGoogle Scholar
  51. 51.
    Berliner DL, Dougherty TF (1961) Hepatic and extrahepatic regulation of corticosteroids. Pharmacol Rev 13:329–359Google Scholar
  52. 52.
    Klein A, Buskila D, Gladman D, Bruser B, Malkin A (1990) Cortisol catabolism by lymphocytes of patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 17:30–33PubMedGoogle Scholar
  53. 53.
    Rook GAW, Honour J, Kon OM, Wilkinson RJ, Davidson R, Shaw RJ (1996) Urinary steroid metabolites in tuberculosis; a new clue to pathogenesis. Q J Med 89:333–341Google Scholar
  54. 54.
    Baker R, Zumla A, Rook GAW (1996) Tuberculosis, steroid metabolism and immunity. QJ Med 89:387–394Google Scholar
  55. 55.
    Hennebold JD, Mu H-H, Poynter ME, Chen X-P, Daynes RA (1997) Active catabolism of glucocorticoids by 11ß-hydroxytseroid dehydrogenase in vivo is a necessary requirement for natural resistance to infection with Listeria monocytogenes. Int Immunol 9:105–115PubMedGoogle Scholar
  56. 56.
    Hubbard WC, Bickel C, Schleimer RP. Simultaneous quantitation of endogenous levels of cortisone and cortisol in human nasal and bronchoalveolar lavage fluids and plasma via gas chromatography-negative ion chemical ionization mass spectrometry. Anal Biochem 221:109–117Google Scholar
  57. 57.
    Walker BR (1994) Organ-specific actions of 11-beta-hydroxysteroid dehydrogenase in humans: implications for the pathophysiology of hypertension. Steroids 59:84–89PubMedGoogle Scholar
  58. 58.
    Daynes RA, Araneo BA, Hennebold J, Enioutina J, Mu HH (1995) Steroids as regulators of the mammalian immune response. J Invest Dermatol 105:14S–19SPubMedGoogle Scholar
  59. 59.
    Evangelatou M, Antoniw J, Cooke BA (1996) The effect of leukocytes on 11ß-HSD activity in human granulosa cell cultures. J Endocrinol 148 (Suppl):abstract P55Google Scholar
  60. 60.
    Elliott LH, Levay AK, Sparks B, Miller M, Roszman TL (1996) Dexamethasone and prostaglandin E2 modulate T-cell receptor signaling through a cAMP-independent mechanism. Cell Immunol 169:117–24PubMedGoogle Scholar
  61. 61.
    Elliott L, Brooks W, Roszman T (1992) Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination. Cell Mol Neurobiol 12:411–427PubMedGoogle Scholar
  62. 62.
    Ayroldi E, Cannarile L, Migliorati G, Bartoli A, Nicoletti I, Riccardi C (1995) CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood 86:2672–2678PubMedGoogle Scholar
  63. 63.
    Brunetti M, Martelli N, Colasante A, Piantelli M, Musiani P, Aiello FB (1995) Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood 86:4199–4205PubMedGoogle Scholar
  64. 64.
    Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895–1902PubMedGoogle Scholar
  65. 65.
    Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T et al. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68–71PubMedGoogle Scholar
  66. 66.
    Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T et al. (1996) An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 183:277–282PubMedGoogle Scholar
  67. 67.
    Rook GAW, Hernandez-Pando R (1996) The pathogenesis of tuberculosis. Annu Rev Microbiol 50:259–284PubMedGoogle Scholar
  68. 68.
    Nishino T, Bernhagen J, Shiiki H, Calandra T, Dohi K, Bucala R (1995) Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med 1:781–788PubMedGoogle Scholar
  69. 69.
    Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y (1987) P-450 HFLa, a form of cytochrome P-450 purified from human foetal livers, is the 16a-hydroxylase of dehydroepiandrosterone 3-sulphate. J Biol Chem 262:13534–13537PubMedGoogle Scholar
  70. 70.
    Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 14:353–356PubMedGoogle Scholar
  71. 71.
    Hill JA, Polgar K, Anderson DJ (1995) T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 273:1933–1936PubMedGoogle Scholar
  72. 72.
    Robel P, Baulieu EE (1995) Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Ann NY Acad Sci 774:82–110PubMedGoogle Scholar
  73. 73.
    Morfin R, Courchay G (1994) Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J Steroid Biochem Molec Biol 50:91–100PubMedGoogle Scholar
  74. 74.
    Wilder RL (1995) Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13:307–338PubMedGoogle Scholar
  75. 75.
    Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, Friedman G (1995) Dehydroepiandrosterone enhances influenza vaccination in aged mice. Ann NY Acad Sci 774:297–299PubMedGoogle Scholar
  76. 76.
    Rasmussen KR, Martin EG, Healey MC (1993) Effects of dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum. J Parasitol 79:364–370PubMedGoogle Scholar
  77. 77.
    Olsen NJ, Zhou P, Ong H (1993) Testosterone induces expression of transforming growth factor-ß in the murine thumus. Steroid Biochem Mol Biol 45:327–332Google Scholar
  78. 78.
    Garg M, Bondada S (1993) Reversal of age-associated decline in immune response to Pnu-immune vaccine by supplementation with the steroid hormone dehydroepiandrosterone. Infect Immun 61:2238–2241PubMedGoogle Scholar
  79. 79.
    Daynes RA, Araneo BA, Ershler WB, Maloney C, Li G-Z, Ryu S-Y (1993) Altered regulation of IL-6 production with normal aging; possible linkage to the age-associated decline in dehydroepiandrosterone and its sulphated derivative. J Immunol 150:5219–5230PubMedGoogle Scholar
  80. 80.
    Morales AJ, Nolan J, Nelson J, Yen AS (1994) Effects of replacement dose of DHEA in men and women of advancing age. J Clin Endocrinol Metab 78:1360–1367PubMedGoogle Scholar
  81. 81.
    Daynes RA, Araneo BA (1989) Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors IL-2 and IL-4. Eur J Immunol 19:2319–2325PubMedGoogle Scholar
  82. 82.
    Daynes RA, Meikle AW, Araneo BA (1991) Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. Res Immunol 142:40–45PubMedGoogle Scholar
  83. 83.
    Suzuki T, Suzuki N, Daynes RA, Engleman EG (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 61:202–211PubMedGoogle Scholar
  84. 84.
    Meikle AW, Dorchuck RW, Araneo BA, Stringham JD, Evans TG, Spruance SL et al. (1992) The presence of a dehydroepiandrosterone-specific receptor-binding complex in murine T cells. J Steroid Biochem Molec Biol 42:293–304PubMedGoogle Scholar
  85. 85.
    Jesse RL, Loesser K, Eich DM, Qian YZ, Hess ML, Nestler JE (1995) Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. Ann NY Acad Sci 774:281–290PubMedGoogle Scholar
  86. 86.
    Peters JM, Yuan-Chun Z, Ram PA, Lee SST, Gonzalez FJ, Waxman DJ (1996) Peroxisome proliferator-activated receptor a required for gene induction by dehydroepiandrosterone-3ß-sulphate. Mol Pharmacol 50:67–74PubMedGoogle Scholar
  87. 87.
    Spencer NFL, Poynter ME, Henebold JD, Mu HH, Daynes RA (1995) Does DHEAS restore immune competence in aged animals through its capacity to function as a natural modulator of peroxisome activities? Ann NY Acad Sci 774:201–216Google Scholar
  88. 88.
    Devchand PR, Keller H, Peters JM, Vasquez M, Gonzalez FJ, Wahli W (1996) The PPARa-leukotriene B4 pathway to inflammation control. Nature 384:39–43PubMedGoogle Scholar
  89. 89.
    Padgett DA, Loria RM (1994) In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol and androstenetriol. J Immunol 153:1544–1552PubMedGoogle Scholar
  90. 90.
    Glaser R, Lafuse WP, Bonneau RH, Atkinson C, Kiecolt GJ (1993) Stress-associated modulation of proto-oncogene expression in human peripheral blood leukocytes. Behav Neurosci 107:525–529PubMedGoogle Scholar
  91. 91.
    Tobach E, Bloch H. Effect of stress by crowding prior to and following tuberculous infection. Am J Physiol 187:399–402Google Scholar
  92. 92.
    Hernandez-Pando R, Rook GAW (1994) The role of TNFa in T cell-mediated inflammation depends on the Thl/Th2 cytokine balance. Immunology 82:591–595PubMedGoogle Scholar
  93. 93.
    Jenkins JK, Malyak M, Arend WP. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils. Lymphokine Cytokine Res 13:47–54Google Scholar
  94. 94.
    Herbelin A, Elhadad S, Ouaaz F, de-Groote D, Descamps-Latscha B (1994) Soluble CD23 potentiates interleukin-1-induced secretion of interleukin-6 and interleukin-1 receptor antagonist by human monocytes. Eur J Immunol 24:1869–1873PubMedGoogle Scholar
  95. 95.
    Muzio M, Re F, Sironi M, Polentarutti N, Minty A, Caput D et al. (1994) Interleukin13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (Keratinocyte) form of IL-1ra in human myelomonocytic cells. Blood 83:1738–1743PubMedGoogle Scholar
  96. 96.
    Sone S, Orino E, Mizuno K, Yano S, Nishioka Y, Haku T et al. (1994) Production of IL-1 and its receptor antagonist is regulated differently by IFN-gamma and IL-4 in human monocytes and alveolar macrophages. Eur Respir J 7:657–663PubMedGoogle Scholar
  97. 97.
    Jenkins JK, Arend WP (1993) Interleukin 1 receptor antagonist production in human monocytes is induced by IL-1 alpha, IL-3, IL-4 and GM-CSF. Cytokine 5:407–415PubMedGoogle Scholar
  98. 98.
    Hernandez-Pando R, Orozco H, Sampieri A, Pavón L, Velasquillo C, Larriva-Sand J et al. (1996) Correlation between the kinetics of Thl/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 89:26–33PubMedGoogle Scholar
  99. 99.
    Schotanus K, Tilders FJ, Berkenbosch F. Human recombinant interleukin-1 receptor antagonist prevents adrenocorticotropin, but not interleukin-6 responses to bacterial endotoxin in rats. Endocrinology 133:2461–2468Google Scholar
  100. 100.
    Ebisui O, Fukata J, Murakami N, Kobayashi H, Segawa H, Muro S et al. (1994) Effect of IL-1 receptor antagonist and antiserum to TNF-alpha on LPS-induced plasma ACTH and corticosterone rise in rats. Am J Physiol 266:E986–E992PubMedGoogle Scholar
  101. 101.
    Kakucska I, Qi Y, Clark BD, Lechan RM (1993) Endotoxin-induced corticotropinreleasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 133:815–821PubMedGoogle Scholar
  102. 102.
    Laye S, Bluthe RM, Kent S, Combe C, Medina C, Parnet P et al. (1995) Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol 268:R1327–1331PubMedGoogle Scholar
  103. 103.
    Zuckerman SH, Shellhaas J, Butler JD (1989) Differential regulation of lipopolysaccharide-induced interleukin 1 and tumour necrosis factor synthesis; effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19:301–305PubMedGoogle Scholar
  104. 104.
    Bertini R, Bianchi M, Ghezzi P (1988) Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med 167:1708–1712PubMedGoogle Scholar
  105. 105.
    Rook GAW, Bloom BR (1994) Mechanisms of pathogenesis in tuberculosis. In: Bloom BR (ed) Tuberculosis; pathogenesis, protection and control. ASM Press, Washington DC, pp 485–501Google Scholar
  106. 106.
    Kaplan G. Cytokine regulation of disease progression in leprosy and tuberculosis. Immunobiology 191:564–568Google Scholar
  107. 107.
    Chan J, Xing Y, Magliozzo RS, Bloom BR (1992) Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175:1111–1122PubMedGoogle Scholar
  108. 108.
    Wisniewski TL, Hilton CW, Morse EV, Svec F (1993) The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness. Am J Med Sci 305:79–83PubMedGoogle Scholar
  109. 109.
    Donald PR, Beyers N, Rook GAW (1996) Adolescent tuberculosis. S Afr Med J 86:231–233PubMedGoogle Scholar
  110. 110.
    de-Peretti E, Forest MG (1978) Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production. J Clin Endocrinol Metab 47:572–577PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1997

Authors and Affiliations

  • G. A. W. Rook
  • R. Hernandez-Pando
  • R. Baker
  • H. Orozco
  • K. Arriaga
  • L. Pavon
  • M. Streber

There are no affiliations available

Personalised recommendations